Epigenetic aberrations and cancer
-
Corresponding authors: Miryam Ducasse ducasse@em.uni-frankfurt.de - Mark A Brown sambrown750@gmail.com
Molecular Cancer 2006, 5:60 doi:10.1186/1476-4598-5-60
Accesses
- Last 30 days: 120 accesses
- Last 365 days: 1445 accesses
- All time: 9231 accesses
Cited by
BioMed Central: 3 citations
|
Research article
Histone H1x is highly expressed in human neuroendocrine cells and tumours Julia Warneboldt, Florian Haller, Olaf Horstmann, Bernhard C Danner, László Füzesi, Detlef Doenecke, Nicole Happel BMC Cancer 2008, 8:388 (24 December 2008) |
|
Research
Identification of metabolites with anticancer properties by computational metabolomics Adrian K Arakaki, Roman Mezencev, Nathan J Bowen, Ying Huang, John F McDonald, Jeffrey Skolnick Molecular Cancer 2008, 7:57 (17 June 2008) The fully automated computational metabolomics method CoMet examined metabolite levels in cancer cells and provides evidence that intracellular concentrations of antiproliferative metabolites may be decreased in these cells.
|
|
Research
Epigenetic hereditary transcription profiles II, aging revisited Johannes WIM Simons Biology Direct 2007, 2:39 (28 December 2007) |